Tachyon Ventures
Tachyon Ventures is a venture capital firm investing early-stage smart capital in entrepreneurs pushing the boundaries of medicine, biotech, and bioengineering. They focus on transformative technologies at the forefront of these fields, backing teams with world-leading published research and protected intellectual property. Their investment thesis centers on scientific risk-arbitrage, pricing scientific risk earlier than others to maximize upside potential while mitigating risk through collaboration with top scientists and protected IP. Tachyon supports companies developing disruptive platforms in areas such as genetic medicines, RNA therapies, gene therapies, neurodegenerative disease treatments, CRISPR-based biosensing, and monoclonal antibody drug discovery. They have a portfolio including companies like Stylus Medicine, AI Proteins, miRecule, Mammoth Biosciences, and others, reflecting a strong position in early-stage biotech innovation.
Tachyon Ventures
Tachyon Ventures is a venture capital firm investing early-stage smart capital in entrepreneurs pushing the boundaries of medicine, biotech, and bioengineering. They focus on transformative technologies at the forefront of these fields, backing teams with world-leading published research and protected intellectual property. Their investment thesis centers on scientific risk-arbitrage, pricing scientific risk earlier than others to maximize upside potential while mitigating risk through collaboration with top scientists and protected IP. Tachyon supports companies developing disruptive platforms in areas such as genetic medicines, RNA therapies, gene therapies, neurodegenerative disease treatments, CRISPR-based biosensing, and monoclonal antibody drug discovery. They have a portfolio including companies like Stylus Medicine, AI Proteins, miRecule, Mammoth Biosciences, and others, reflecting a strong position in early-stage biotech innovation.